Víctor Daniel Rosenthal1, Ider Bat-Erdene2, Debkishore Gupta3, Souad Belkebir4, Prasad Rajhans5, Farid Zand6, Sheila Nainan Myatra7, Majeda Afeef8, Vito L Tanzi9, S Muralidharan10, Vaidotas Gurskis11, Hail M Al-Abdely12, Amani El-Kholy13, Safa A Aziz AlKhawaja14, Suha Sen15, Yatin Mehta16, Vineya Rai17, Nguyen Viet Hung18, Amani F Sayed19, Fausto Marcos Guerrero-Toapanta20, Naheed Elahi21, María Del Rayo Morfin-Otero22, Suwara Somabutr23, Braulio Matias De-Carvalho24, Mary Shine Magdarao25, Velmira Angelova Velinova26, Ana Marcela Quesada-Mora27, Tanja Anguseva28, Aamer Ikram29, Daisy Aguilar-de-Moros30, Wieslawa Duszynska31, Nepomuceno Mejia32, Florin George Horhat33, Vladislav Belskiy34, Vesna Mioljevic35, Gabriela Di-Silvestre36, Katarina Furova37, May Osman Gamar-Elanbya38, Umesh Gupta39, Khalid Abidi40, Lul Raka41, Xiuqin Guo42, Marco Tulio Luque-Torres43, Kushlani Jayatilleke44, Najla Ben-Jaballah45, Achilleas Gikas46, Harrison Ronald Sandoval-Castillo47, Andrew Trotter48, Sandra L Valderrama-Beltrán49, Hakan Leblebicioglu50. 1. Infection Control Department, International Nosocomial Infection Control Consortium, Buenos Aires, Argentina. Electronic address: victor_rosenthal@inicc.org. 2. Infection Control Department, Infection Control Professionals of Mongolia, and Intermed Hospital, Ulaanbaatar, Mongolia. 3. Infection Control Department, BM Birla Heart Research Centre, and The Calcutta Medical Research Institute, Calcutta, India. 4. Infection Control Department, An Najah National University Hospital, Nablus, Palestine. 5. Infection Control Department, Deenanath Mangeshkar Hospital, Pune, India. 6. Infection Control Department, Anesthesiology and Critical Care Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran. 7. Infection Control Department, Tata Memorial Hospital, Mumbai, India. 8. Infection Control Department, King Hussein Cancer Center, Amman, Jordan. 9. Infection Control Department, Hammoud Hospital University Medical Center, Saida, Lebanon. 10. Infection Control Department, G Kuppusamy Naidu Memorial Hospital, Coimbatore, India. 11. Infection Control Department, Hospital of Lithuanian University of Health Sciences, Kaunas, Lithuania. 12. Infection Control Department, General Directorate of Infection Prevention and Control, Ministry of Health, Kingdom of Saudi Arabia. 13. Infection Control Department, Dar Al Fouad Hospital, 6th of October City, and Cairo University Hospital, Cairo; Egypt. 14. Infection Control Department, General Directorate of Infection Prevention and Control, Ministry of Health, Bahrain. 15. Infection Control Department, Turkiye Yuksek Ihtisas Education And Research Hospital, Ankara, Turkey. 16. Infection Control Department, Medanta The Medicity, New Delhi, India. 17. Infection Control Department, University Malaya Medical Centre, Kuala Lumpur, Malaysia. 18. Infection Control Department, Bach Mai Hospital, Hanoi, Vietnam. 19. Infection Control Department, Farwaniya Hospital, Kuwait City, Kuwait. 20. Infection Control Department, Hospital Carlos Andrade Marin, Quito, Ecuador. 21. Infection Control Department, Dubai Hospital, Dubai, United Arab Emirates. 22. Infection Control Department, Hospital Civil de Guadalajara Fray Antonio Alcalde Infection Control Committee, Guadalajara, Mexico. 23. Infection Control Department, Bangpakok 9 International Hospital, Pratumthani, Thailand. 24. Infection Control Department, Hospital de Messejana, Fortaleza, Brazil. 25. Makati Medical Center, Makati, Philippines. 26. Queen Giovanna Isul, Sofia, Bulgaria. 27. Hospital Clínica Bíblica, San Jose, Costa Rica. 28. Special Hospital for Surgical Diseases Filip Vtori, Skopje, Macedonia. 29. Armed Forces Institute of Pathology, Rawalpindi, Pakistan. 30. Hospital del Niño de Panama, Panama. 31. Wroclaw University Hospital, Wroclaw, Poland. 32. Hospital General de La Plaza de La Salud, Santo Domingo, Dominican Republic. 33. University of Medicine and Pharmacy Victor Babes Timisoara Emergency County Clinical Hospital, Timisoara, Romania. 34. Privolzhskiy District Medical Center, Nizhniy Novgorod, Russia. 35. Clinical Center of Serbia, Belgrade, Serbia. 36. Hospital de Clínicas Caracas, Caracas, Venezuela. 37. Catholic University in Ruzomberok Faculty Of Health Central Military Hospital Ruzomberok, Ruzomberok, Slovakia. 38. Royal Care International Hospital, Khartoum, Sudan. 39. Port Moresby General Hospital, Port Moresby, Papua New Guinea. 40. Ibn Sina Hospital of Morocco, Rabat, Morocco. 41. National Institute for Public Health of Kosovo and Medical School, Prishtina University, Prishtina, Kosovo. 42. Dong E Peoples Hospital, Shandong, People's Republic of China. 43. Hospital de Especialidades del Instituto Hondureño de Seguridad Social, Tegucigalpa, Honduras. 44. Sri Jayewardenepura General Hospital, Nugegoda, Sri Lanka. 45. Children Hospital Bechir Hamza of Tunis, Tunis, Tunisia. 46. University General Hospital of Heraklion, Athens, Greece. 47. Clínica Ricardo Palma, Lima, Peru. 48. Grande International Hospital, Kathmandu, Nepal. 49. Pontificia Universidad Javeriana Hospital Universitario San Ignacio, Bogotá, Colombia. 50. Ondokuz Mayis University Medical School, Samsun, Turkey.
Abstract
BACKGROUND: We report the results of International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2012 to December 2017 in 523 intensive care units (ICUs) in 45 countries from Latin America, Europe, Eastern Mediterranean, Southeast Asia, and Western Pacific. METHODS: During the 6-year study period, prospective data from 532,483 ICU patients hospitalized in 242 hospitals, for an aggregate of 2,197,304 patient days, were collected through the INICC Surveillance Online System (ISOS). The Centers for Disease Control and Prevention-National Healthcare Safety Network (CDC-NHSN) definitions for device-associated health care-associated infection (DA-HAI) were applied. RESULTS: Although device use in INICC ICUs was similar to that reported from CDC-NHSN ICUs, DA-HAI rates were higher in the INICC ICUs: in the medical-surgical ICUs, the pooled central line-associated bloodstream infection rate was higher (5.05 vs 0.8 per 1,000 central line-days); the ventilator-associated pneumonia rate was also higher (14.1 vs 0.9 per 1,000 ventilator-days,), as well as the rate of catheter-associated urinary tract infection (5.1 vs 1.7 per 1,000 catheter-days). From blood cultures samples, frequencies of resistance, such as of Pseudomonas aeruginosa to piperacillin-tazobactam (33.0% vs 18.3%), were also higher. CONCLUSIONS: Despite a significant trend toward the reduction in INICC ICUs, DA-HAI rates are still much higher compared with CDC-NHSN's ICUs representing the developed world. It is INICC's main goal to provide basic and cost-effective resources, through the INICC Surveillance Online System to tackle the burden of DA-HAIs effectively.
BACKGROUND: We report the results of International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2012 to December 2017 in 523 intensive care units (ICUs) in 45 countries from Latin America, Europe, Eastern Mediterranean, Southeast Asia, and Western Pacific. METHODS: During the 6-year study period, prospective data from 532,483 ICU patients hospitalized in 242 hospitals, for an aggregate of 2,197,304 patient days, were collected through the INICC Surveillance Online System (ISOS). The Centers for Disease Control and Prevention-National Healthcare Safety Network (CDC-NHSN) definitions for device-associated health care-associated infection (DA-HAI) were applied. RESULTS: Although device use in INICC ICUs was similar to that reported from CDC-NHSN ICUs, DA-HAI rates were higher in the INICC ICUs: in the medical-surgical ICUs, the pooled central line-associated bloodstream infection rate was higher (5.05 vs 0.8 per 1,000 central line-days); the ventilator-associated pneumonia rate was also higher (14.1 vs 0.9 per 1,000 ventilator-days,), as well as the rate of catheter-associated urinary tract infection (5.1 vs 1.7 per 1,000 catheter-days). From blood cultures samples, frequencies of resistance, such as of Pseudomonas aeruginosa to piperacillin-tazobactam (33.0% vs 18.3%), were also higher. CONCLUSIONS: Despite a significant trend toward the reduction in INICC ICUs, DA-HAI rates are still much higher compared with CDC-NHSN's ICUs representing the developed world. It is INICC's main goal to provide basic and cost-effective resources, through the INICC Surveillance Online System to tackle the burden of DA-HAIs effectively.
Authors: Victor Daniel Rosenthal; Ruijie Yin; Sandra Liliana Valderrama-Beltran; Sandra Milena Gualtero; Claudia Yaneth Linares; Guadalupe Aguirre-Avalos; Julio Cesar Mijangos-Méndez; Miguel Ángel Ibarra-Estrada; Luisa Fernanda Jimenez-Alvarez; Lidia Patricia Reyes; Carlos Arturo Alvarez-Moreno; Maria Adelia Zuniga-Chavarria; Ana Marcela Quesada-Mora; Katherine Gomez; Johana Alarcon; Jose Millan Oñate; Daisy Aguilar-De-Moros; Elizabeth Castaño-Guerra; Judith Córdoba; Alejandro Sassoe-Gonzalez; Claudia Marisol Millán-Castillo; Lissette Leyva Xotlanihua; Lina Alejandra Aguilar-Moreno; Juan Sebastian Bravo Ojeda; Ivan Felipe Gutierrez Tobar; Mary Cruz Aleman-Bocanegra; Clara Veronica Echazarreta-Martínez; Belinda Mireya Flores-Sánchez; Yuliana Andrea Cano-Medina; Edwin Giovannny Chapeta-Parada; Rafael Antonio Gonzalez-Niño; Maria Isabel Villegas-Mota; Mildred Montoya-Malváez; Miguel Ángel Cortés-Vázquez; Eduardo Alexandrino Medeiros; Dayana Fram; Daniela Vieira-Escudero; Zhilin Jin Journal: J Epidemiol Glob Health Date: 2022-10-05
Authors: E Glover; A Abrahamson; J Adams; S R Poken; S-L Hainsworth; A Lamprecht; T Delport; T Keulder; T Olivier; S D Maasdorp Journal: Afr J Thorac Crit Care Med Date: 2022-05-05
Authors: Inam Danish Khan; Geetanjali Gonimadatala; S Narayanan; Umesh Kapoor; Harleen Kaur; Anuradha Makkar; R M Gupta Journal: Med J Armed Forces India Date: 2021-10-28